Tenofovir: Gilead applies for approval; expanded access liberalized.

Article Details

Citation
Copy to clipboard

Gilden D

Tenofovir: Gilead applies for approval; expanded access liberalized.

AIDS Treat News. 2001 May 11;(364):2-3, 1.

PubMed ID
11569959 [ View in PubMed
]
Abstract

Patients who cannot construct a viable antiretroviral regimen with approved drugs will now have easier access to tenofovir, a drug that is currently experimental but may be approved in about six months. Tenofovir is significant because it appears to maintain its antiretroviral activity, with resistant HIV developing relatively slowly.

DrugBank Data that Cites this Article

Drugs